🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase II open-label, uncontrolled, multicenter trial is designed to in...
Status
Completed
Location
Cincinnatti Childrens Hospital
Start Date
2022-09-21
Trial ID
NCT05590884
Treatments Being Tested
The trial aimed at evaluating the efficacy and the safety of gadopiclenol f...
Status
Completed
Location
The University of Alabama at Birmingham
Start Date
2019-08-27
Trial ID
NCT03986138
Treatments Being Tested
The purpose of this study was to determine a safe and effective dose of a n...
Status
Completed
Location
Northwestern memorial hospital
Start Date
2016-06
Trial ID
NCT02633501
Treatments Being Tested
The goal of this study is to assess the value of liver dynamic contrast-enh...
Status
Enrolling By Invitation
Location
Mount Sinai
Start Date
2024-02-28
Trial ID
NCT06703450
This single center, single ascending dose, double blind, randomized, placeb...
Status
Completed
Location
Hataka clinic
Start Date
2021-05-10
Trial ID
NCT04906005
Treatments Being Tested
This is an open-label, non-randomized, successive cohorts design, multicent...
Status
Completed
Location
Republican Clinical Hospital, Arensia EM Unit
Start Date
2017-10-13
Trial ID
NCT03657784
Treatments Being Tested
To learn if gadopiclenol (a contrast agent) used during MRI scanning can he...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2026-06-10
Trial ID
NCT07415018
This is a pharmacokinetics (PK), open-label, uncontrolled, multicenter phas...
Status
Completed
Location
MHAT Central Onco Hospital Ltd
Start Date
2018-11-06
Trial ID
NCT03749252
Treatments Being Tested
The purpose of this pilot study is to compare a standard of care MRI scan t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12-30
Trial ID
NCT06127810
Treatments Being Tested
The primary objective of this study was to evaluate the safety (clinical an...
Status
Completed
Location
Clinical Pharmacology unit, SGS Life Science Services
Start Date
2013-11-25
Trial ID
NCT03603106